Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Kalil

Showing results (311-320 of 345) with videos related to

Pageof 35
Sort By:
Journal of the American Heart Association|April 7, 2026
Elevated Interleukin-6 Levels in Socioeconomically Disadvantaged Children With Borderline Subclinical Rheumatic Heart Disease in São Paulo, Brazil: A Prospective Cohort Study Highlighting Early Detection and Treatment OpportunitiesCarlos Eduardo de Barros Branco, Alessandra Santos Lima Gazola, Carlos Augusto Homem de Magalhães Campos, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|November 29, 2023
Thinking out of the box: revisiting health surveillance based on medical recordsVanderson S Sampaio, Rafael Lopes, Mina Cintho Ozahata, et al.
Frontiers in Immunology|March 18, 2022
Reduced T Cell and Antibody Responses to Inactivated Coronavirus Vaccine Among Individuals Above 55 Years OldGiuliana X Medeiros, Greyce Luri Sasahara, Jhosiene Y Magawa, et al.
Clinical Immunology (Orlando, Fla.)|April 4, 2025
Neutralizing antibody responses after a two-dose regimen with BNT162b2, CoronaVac or ChAdOx1-S in Brazil: Differential neutralization of SARS-CoV-2 omicron variantsIsabela Pazotti Daher, Bianca da Silva Almeida, Guilherme Antonio de Souza-Silva, et al.
Frontiers in Immunology|August 1, 2025
Adjuvant combination and antigen multimerization shape neutralizing antibody and T cell responses to a SARS-CoV-2 RBD subunit vaccineJoão Pedro da Silva Nunes, Mariângela de Oliveira Silva, Juliana de Souza Apostolico, et al.
Plos One|November 17, 2011
Immunogenicity and reactogenicity of 2009 influenza A (H1N1) inactivated monovalent non-adjuvanted vaccine in elderly and immunocompromised patientsJoão L Miraglia, Edson Abdala, Paulo M Hoff, et al.
Journal of Virology|September 8, 2017
Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue VaccineDiogo M Magnani, Cassia G T Silveira, Michael J Ricciardi, et al.
Nature Communications|October 27, 2021
Rhesus macaques self-curing from a schistosome infection can display complete immunity to challengeMurilo Sena Amaral, Daisy Woellner Santos, Adriana S A Pereira, et al.
Virology|July 25, 2025
Murine antibody 4B1D3 exhibits broad cross-reactivity and neutralizing activity against SARS-CoV-2 variantsMariângela de Oliveira Silva, Isabela Pazotti Daher, Catarina Harumi Oda Ibrahim, et al.
Advances in Rheumatology (London, England)|May 22, 2023
A brazilian nationwide multicenter study on deficiency of deaminase-2 (DADA2)Adriana Melo, Luciana Martins de Carvalho, Virginia Paes Leme Ferriani, et al.
Pageof 35

Showing results (311-320 of 345) with videos related to

Sort By:
Pageof 35
Journal of the American Heart Association|April 7, 2026
Elevated Interleukin-6 Levels in Socioeconomically Disadvantaged Children With Borderline Subclinical Rheumatic Heart Disease in São Paulo, Brazil: A Prospective Cohort Study Highlighting Early Detection and Treatment OpportunitiesCarlos Eduardo de Barros Branco, Alessandra Santos Lima Gazola, Carlos Augusto Homem de Magalhães Campos, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|November 29, 2023
Thinking out of the box: revisiting health surveillance based on medical recordsVanderson S Sampaio, Rafael Lopes, Mina Cintho Ozahata, et al.
Frontiers in Immunology|March 18, 2022
Reduced T Cell and Antibody Responses to Inactivated Coronavirus Vaccine Among Individuals Above 55 Years OldGiuliana X Medeiros, Greyce Luri Sasahara, Jhosiene Y Magawa, et al.
Clinical Immunology (Orlando, Fla.)|April 4, 2025
Neutralizing antibody responses after a two-dose regimen with BNT162b2, CoronaVac or ChAdOx1-S in Brazil: Differential neutralization of SARS-CoV-2 omicron variantsIsabela Pazotti Daher, Bianca da Silva Almeida, Guilherme Antonio de Souza-Silva, et al.
Frontiers in Immunology|August 1, 2025
Adjuvant combination and antigen multimerization shape neutralizing antibody and T cell responses to a SARS-CoV-2 RBD subunit vaccineJoão Pedro da Silva Nunes, Mariângela de Oliveira Silva, Juliana de Souza Apostolico, et al.
Plos One|November 17, 2011
Immunogenicity and reactogenicity of 2009 influenza A (H1N1) inactivated monovalent non-adjuvanted vaccine in elderly and immunocompromised patientsJoão L Miraglia, Edson Abdala, Paulo M Hoff, et al.
Journal of Virology|September 8, 2017
Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue VaccineDiogo M Magnani, Cassia G T Silveira, Michael J Ricciardi, et al.
Nature Communications|October 27, 2021
Rhesus macaques self-curing from a schistosome infection can display complete immunity to challengeMurilo Sena Amaral, Daisy Woellner Santos, Adriana S A Pereira, et al.
Virology|July 25, 2025
Murine antibody 4B1D3 exhibits broad cross-reactivity and neutralizing activity against SARS-CoV-2 variantsMariângela de Oliveira Silva, Isabela Pazotti Daher, Catarina Harumi Oda Ibrahim, et al.
Advances in Rheumatology (London, England)|May 22, 2023
A brazilian nationwide multicenter study on deficiency of deaminase-2 (DADA2)Adriana Melo, Luciana Martins de Carvalho, Virginia Paes Leme Ferriani, et al.
Pageof 35